Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

Authors	OSTERBORG A. JEWELL R.C. PADMANABHAN-IYER S. KIPPS T.J. MAYER Jiří STILGENBAUER S. WILLIAMS C.D. HELLMANN A. FURMAN R.R. ROBAK T. HILLMAN P. TRNENY M. DYER M.J.S. PIOTROWSKA M. KOZAK T. GUPTA I.V. PHILLIPS J.L. GOLDSTEIN N. STRUEMPER H. LOSIC N. LISBY S. WIERDA W.G.
Year of publication	2015
Type	Article in Periodical
Magazine / Source	Haematologica
MU Faculty or unit	Faculty of Medicine
Citation
Doi	http://dx.doi.org/10.3324/haematol.2014.121459
Field	Oncology and hematology
Keywords	ofatumumab; fludarabine-refractory; pivotal study
Description	Study of Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study.